SCHEMBL7984955

SCHEMBL7984955

O=c1nc(-c2ccc(O)c(O)c2)[nH]c2ncn(Cc3ccccc3)c12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 6/20 0.51
PARN O95453 1/20 0.51
GUSB P08236 2/20 0.46
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.41
PNP P00491 2/20 0.41
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MTOR P42345 1/20 0.38
ADORA2B P29275 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988562 0.88 CNOT7 (0.54) CNOT7PARNGUSBALDH1A1SMN1; SMN2
SCHEMBL7985342 0.87 CNOT7 (0.51) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7988790 0.87 CNOT7 (0.53) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7975271 0.86 CNOT7 (0.56) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7984461 0.84 CNOT7 (0.52) CNOT7PARNGUSBALDH1A1SMN1; SMN2
SCHEMBL7975135 0.84 CNOT7 (0.52) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7984891 0.84 CNOT7 (0.50) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7984663 0.83 CNOT7 (0.49) CNOT7PARNALDH1A1SMN1; SMN2HPGD
SCHEMBL7974015 0.83 PARN (0.49) CNOT7PARNALDH1A1SMN1; SMN2PNP
SCHEMBL7974508 0.83 CNOT7 (0.51) CNOT7PARNALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed